crypto article, Featured snippets

The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)AIA: It cost about HK$ 62.73 million to buy back nearly 1.07 million shares. AIA Holdings Limited announced that it spent about HK$ 62.73 million to buy back about 1.07 million shares that day, accounting for 0.0098% of the issued shares, and the repurchase price per share ranged from HK$ 563,84942 to HK$ 598,0954.UN Secretary-General Guterres: I fully believe that the Syrian people can choose their own destiny.

Kremlin: (When asked whether the fall of Assad weakened Russia's influence in the Middle East) Military action in Ukraine is a top priority.Health Yuan: Obtained the commitment letter of stock repurchase loan from financial institutions of no more than 238 million yuan. Health Yuan announcement, the company recently obtained the commitment letter of loan from Industrial Bank, with a loan amount of no more than 238 million yuan, no more than 90% of the upper limit of repurchase amount, and a loan period of no more than 36 months, which is specially used to repurchase shares of listed companies. The total amount of the company's actual loan and the amount of the repurchased funds shall not exceed the upper limit of the amount of this repurchase program. The commitment letter of the financial institution's stock repurchase loan obtained this time does not represent the company's commitment to the repurchase amount. The specific number of shares repurchased shall be subject to the actual number of shares repurchased at the expiration of the repurchase period.India's NIFTY metal index rose by 1.25%.

Traders increased their bets on the Fed's interest rate cut. After the CPI report was released, swap traders increased their bets on the Fed's interest rate cut before the end of 2025. They now predict that by that time, they will cut interest rates by 87 basis points, which means that the Federal Reserve will cut interest rates by 25 basis points next week. In 2025, there will be another two interest rate cuts of 25 basis points each time, which is less than the four times proposed by Fed officials in the latest quarterly bitmap in September.Kremlin: Actions in the Golan Heights and the buffer zone are unlikely to help stabilize the situation in Syria.MERO, the Czech pipeline operator: The oil transportation to the Czech Republic through the "Friendship" pipeline continues to run as planned.